Leo Pharma finds new medical director at Bayer

German national Jörg Möller takes on the role of executive vice president of Global Research and Development from Jan. 1 and succeeds Kim Kjøller, who will be leaving the company at the turn of the year.

Photo: Leo Pharma / PR

Leo Pharma has decided on the person who will replace Kim Kjøller’s position in the pharmaceutical company, as he will be taking up the position of CEO at Union Therapeutics starting next year.

The new man leading Leo’s research and developmental work is Jörg Möller from Germany, who was fetched from Bayer Pharma, where he has held a similar position in the German pharmaceutical firm’s executive group since January 2018.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs